https://www.selleckchem.com/pr....oducts/Gefitinib.htm
The purpose of this study was to identify predictors of healthy arterial aging (long-term coronary artery calcification [CAC] of among individuals with metabolic syndrome (MetS) or type 2 diabetes (T2D), which may improve primary prevention strategies. Individuals with MetS or T2D have a heterogeneously increased risk of atherosclerotic cardiovascular disease and not all have a high-intermediate risk. We included 574 participants from the MESA (Multi-Ethnic Study of Atherosclerosis) with MetS or T2D who had CAC=0 at baseline and a
Like
Comment
Share
